Brazil moves forward with ARVs
This article was originally published in Scrip
Recent developments in antiretroviral treatments in Brazil could mean progress in the fight against HIV/AIDS at home and abroad. Triple combination ARVs – including one formulated for use in Africa – and paediatric formulations are on the way, the Oswaldo Cruz Foundation (Fiocruz), a national research centre, has said.
You may also be interested in...
WTO member states including the EU, the US and the UK argue that waiving certain IP rights is unnecessary for enhancing responses to the Covid-19 pandemic.
Insurers argue that better use of real world data and multiple pricing assessments could help lower drug prices in Germany.
To keep investors happy, companies will have to start showing that their high-priced advanced therapies offset costs elsewhere in the health care system.